Moderna Inc (NASDAQ:MRNA)
| 353.15 BATS BZX Real-Time Price As of 1:27pm ET |  -15.35 / -4.17%Today’s Change | 102.66 Today|||52-Week Range 497.49 | +238.04% Year-to-Date |
Latest MRNA News | Press Releases
| Pre-Markets Down on Omicron Fears 11:13am / Zacks.com - Paid Partner Content | Stock Market News for Nov 30, 2021 9:45am / Zacks.com - Paid Partner Content |
| Moderna (MRNA) Rallies on Booster Hopes Amid Omicron Concerns 10:37am / Zacks.com - Paid Partner Content | The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Moderna and Novavax 8:11am / Zacks.com - Paid Partner Content |
| Reversal on Omicron Prospects Send Markets Down 10:36am / Zacks.com - Paid Partner Content | Nice Relief Rally on Biotech Assurances, Home Sales Data Nov 29 / Zacks.com - Paid Partner Content |
| 9 Words From Moderna's CEO That Could Signal a Boost in Vaccine Orders 10:00am / MotleyFool.com - Paid Partner Content | Philippe Laffont's Top 3rd-Quarter Buys and Latest Real-Time Picks Nov 29 / GuruFocus News - Paid Partner Content |
| J&J (JNJ) to Explore Omicron Version of its COVID Vaccine 10:00am / Zacks.com - Paid Partner Content | Omicron Fears Fuel Rally in Vaccine Stocks: Will It Continue? Nov 29 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 368.50 |
| Today’s open | 351.54 |
| Day’s range | 337.39 - 355.17 |
| Volume | 486,172 |
| Average volume (3 months) | 15,609,027 |
| Market cap | $133.6B |
Data as of 1:27pm ET, 11/30/2021
Growth & Valuation
| Earnings growth (last year) | -26.08% |
| Earnings growth (this year) | +1,452.98% |
| Earnings growth (next 5 years) | -21.63% |
| Revenue growth (last year) | +1,234.34% |
| P/E ratio | 21.7 |
| Price/Sales | 49.59 |
| Price/Book | 51.32 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AMGNAmgen | -2.88 | -1.42% |
| GILDGilead Sciences | -0.52 | -0.74% |
| ILMNIllumina Inc | -3.65 | -0.98% |
| BIIBBiogen | -0.87 | -0.37% |
Data as of 1:27pm ET, 11/30/2021
Financials
| Next reporting date | March 9, 2022 |
| EPS forecast (this quarter) | $8.58 |
| Annual revenue (last year) | $803.4M |
| Annual profit (last year) | -$747.1M |
| Net profit margin | -92.99% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
